ESMOGI24

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

ESMOGI24
Aug 7, 2024, 10:50 | Insight
Lorenza Rimassa: Outcomes in patients with unresectable HCC treated with STRIDE
Lorenza Rimassa, Associate Professor of Medical Oncology at HUNIMED, shared on X: "Glad to discuss…
Jul 17, 2024, 09:44 | Societies
7 interviews summarizing study results from ESMOGI24
The European Society for Medical Oncology (ESMO) shared on LinkedIn: "The Breaking Science in Gastrointestinal…
Jul 9, 2024, 21:43 | Blog
All interviews will be available on Oncology Pro from ESMOGI24
ESMO shared on X: "Oncology Pro was onsite in Munich, interviewing key authors about their groundbreaking…
Jul 7, 2024, 18:32 | Blog
A significant perception gap between patients with Colorectal Cancer and Healthcare Professionals - ESMO
ESMO - European Society for Medical Oncology shared a post on LinkedIn: . "A recent…
Jul 3, 2024, 05:47 | Societies
Keynote lecture on liver cancer by Stephen L Chan
Lorenza Rimassa, Associate Professor of Medical Oncology at HUNIMED, shared on X: "Ready for the…
Jul 2, 2024, 17:21 | Blog
Amalya Sargsyan: One of Oncodaily’s top 10 promising drugs is showing great resuts at ESMOGI24
Amalya Sargsyan shared a post by Pashtoon Kasi, on LinkedIn: "Exciting Updates! 𝐁𝐨𝐭𝐞𝐧𝐬𝐢𝐥𝐢𝐦𝐚𝐛 one of OncoDaily's…
Jul 2, 2024, 14:34 | Blog
All disease begins in the gut
Rodrigo Dienstmann, Oncology Data Scientist at VHIO Digital Health, shared on X: "'All disease begins in…
Jul 2, 2024, 14:21 | Blog
Myriam Chalabi: Juan O'Connor putting NEST-1 and ECOG /study into perspective
Myriam Chalabi shared on X: "Great discussion by Juan OConnor in the mini-oral session ESMOGI24. Putting…
Jul 2, 2024, 11:58 | Blog
Nikolas Naleid: Prognostic role of ctDNA in oligometastatic CRC at ESMOGI24
Nikolas Naleid, Internal Medicine PGY3 resident at Case Western Reserve/UH Cleveland Medical Center, shared on X:…
Jul 2, 2024, 09:22 | Societies
Inspired by engaging with the GI community at ESMOGI24 - Agenus
Agenus shared on LinkedIn: "That's a wrap on ESMOGI24! Our team was inspired by engaging…
Jul 2, 2024, 07:19 | Societies
25 Posts You Should Not Miss From ESMOGI24!
ESMOGI24 took place as an onsite event in Munich, Germany, from 26 to 29 June…
Jul 1, 2024, 02:54 | Blog
Erman Akkus: Take home messages from Proffered Papers session at ESMOGI24
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: “Take home…
Jul 1, 2024, 02:25 | Blog
Insights from ESMOGI24 by Cathy Eng
ESMO GI 2024 took place from June 26 to 29 in Munich, Germany, featuring both…
Jun 30, 2024, 08:07 | Societies
9 Posts You Should Not Miss From Day 3 of ESMOGI24!
ESMOGI24 is taking place as an onsite event in Munich, Germany, from 26 to 29 June 2024,…
Jun 30, 2024, 03:43 | Blog
Pashtoon Kasi: Curative potential of immunotherapy for both MSS and MSI-High tumors
Pashtoon Kasi shared on X: "NEST Trial responses to date. What’s particularly of note is…
Jun 30, 2024, 03:28 | Blog
Erika Ruiz-Garcia: GI oncology team from National Institute of Cancerology will present 6 posters at ESMOGI24
Erika Ruiz-Garcia, Chief of the Translational Medicine Laboratory at the National Institute of Cancerology in Mexico…
Jun 29, 2024, 14:24 | Societies
KRAS - the most commonly mutated oncogene in cancer
Amol Akhade shared on X: "KRAS - the most commonly mutated oncogene in cancer. Nice…
Jun 29, 2024, 13:41 | Societies
ESMOGI24 Key Insights Shared By Megan Barnet
ESMOGI24 is taking place as an onsite event in Munich, Germany, from 26 to 29…
Jun 29, 2024, 13:12 | Societies
Poster on early-onset CCA won Best Poster at ESMOGI24
Natalia Tissera, PhD Student at Vall d'Hebron Institute of Oncology (VHIO), shared on X: "Thrilled…
Jun 29, 2024, 12:39 | Societies
Rachel Riechelmann: Excellent discussion of neoadjuvant IO in colorectal cancer
Rachel Riechelmann shared on X: "Excellent discussion of neoadjuvant IO in colorectal cancer by Juan O'Connor…
Jun 29, 2024, 11:21 | Societies
Highlights from ESMOGI24 by Angela Lamarca
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29…
Jun 29, 2024, 11:05 | Societies
Neoadjuvant botensilimab and balstilimab in colorectal cancer
Smitha Krishnamurthi, Gastrointestinal medical oncologist at Cleveland Clinic, shared on X: "Neoadjuvant botensilimab (1 dose)…
Jun 29, 2024, 10:55 | Societies
Zev Wainberg discussing the 3-year OS data from the TOPAZ-1 trial
Lorenza Rimassa, Associate Professor of Medical Oncology at HUNIMED, shared on X: "Zev Wainberg discussing…
Jun 29, 2024, 10:49 | Societies
The role of gut microbiome in cancer at ESMOGI24
ESMOGI24 is taking place as an onsite event in Munich, Germany, from 26 to 29 June 2024,…
Jun 29, 2024, 10:24 | Societies
Magnus Nilsson discusses when and why we should operate in esophageal cancer
Lizzy Smyth, Consultant Medical Oncologist in upper GI oncology at Oxford University, shared on X:…
Jun 29, 2024, 09:23 | Societies
Unanswered questions in TNT and organ preservation of rectal cancer
Rasha Aboelhassan shared on LinkedIn: "What ever we do? And how much patients we recruit?…
Jun 29, 2024, 06:16 | Societies
Microbiome Research is reshaping colorectal cancer treatment
ESMO shared on LinkedIn: "ESMOGI24: Since the development of Colorectal Cancer (CRC) is intertwined with…
Jun 29, 2024, 00:48 | Blog
Jenny Seligmann: Privilege to share the stage with Jeanne Tie to discuss advances in localised colon cancer
Jenny Seligmann, Professor of Gastrointestinal and Translational Oncology and Honorary Consultant in Medical Oncology at…
Jun 28, 2024, 15:58 | Insight
Updates on BOT/BAL from ESMOGI24
ESMO GI 2024 is held in Munich, Germany, and online from June 26-29. Organized by…
Jun 28, 2024, 13:58 | Societies
EORTC session in gastro-intestinal oncology trials at ESMO GI
The European Organisation for Research and Treatment of Cancer (EORTC) shared on LinkedIn: "Thank you…
Jun 28, 2024, 13:48 | Societies
Peter de Gooyer awarded as the best poster presenter in rectal cancer at ESMOGI24
Chiara Cremolini, Associate Professor in Medical Oncology at the University of Pisa, shared a post…
Jun 28, 2024, 13:48 | Insight
Arndt Vogel: Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at ESMOGI24
Arndt Vogel shared on X: "Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at…
Jun 28, 2024, 13:41 | Insight
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Agenus shared on their X page: "New data from the NEST clinical trial was presented…
Jun 28, 2024, 13:32 | Societies
Updated results from the TRANSMET trial at ESMOGI24
ESMO shared on X: "ESMOGI24: Updated results from the TRANSMET trial showed that chemotherapy combined…
Jun 28, 2024, 13:15 | Insight
The clinical utility of liquid biopsies detecting ctDNA in guiding treatment for patients with mCRC - ESMO
ESMO (European Society for Medical Oncology) shared on LinkedIn: "Data from two presentations at ESMOGI24…
Jun 28, 2024, 13:09 | Insight
Vittorio Studiale: Impressive pathological response rate with neoadjuvant BOT/BAL in MSS CRC
Vittorio Studiale, Medical Oncology Resident at University Hospital of Pisa, shared on X: "Impressive pathological…
Jun 28, 2024, 13:00 | Insight
Cathy Eng: Agenus with very promising data in early MSI-s/MSI-H colon cancer
Cathy Eng shared on X/Twitter: "Bot/Bal immunotherapy in colon cancer NEST 1/2. Agenus with very…
Jun 28, 2024, 12:00 | Societies
Prospective study on the prognostic impact of mutKRAS at ESMOGI24
Giada Grelli, Medical Oncology Resident at University of Pisa, shared on X: "So grateful and…
Jun 28, 2024, 11:47 | Societies
Anwaar Saeed: Thrilled to present mature data from phase 2 CRC expansion cohort
Anwaar Saeed, Associate Professor and Chief of Gastrointestinal Medical Oncology at University of Pittsburgh, shared…
Jun 28, 2024, 11:28 | Societies
Keynote address by Myriam Chalabi at ESMOGI24
Toni Choueiri shared on X: "Keynote address at ESMOGI24 with superstar Myriam Chalabi- Immunotherapy for…
Jun 28, 2024, 11:27 | Societies
12 Posts You Should Not Miss From Day 2 of ESMOGI24!
ESMOGI24 is taking place as an onsite event in Munich, Germany, from 26 to 29 June 2024,…
Jun 28, 2024, 11:14 | Blog
Aparna Parikh: Missing ESMOGI24 but for good reasons
Aparna Parikh shared on X: "Missing ESMOGI24 but for good reasons. Team PROSPECT (Yin Cao,…
Jun 28, 2024, 10:52 | Societies
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
ESMO shared a post on LinkedIn: "ESMOGI24: Colorectal Cancer (CRC) can be classified into two…
Jun 28, 2024, 10:50 | Societies
Rachel Riechelmann: Our multicenter study on colorectal cancer patients treated with CAPOX
Rachel Riechelmann shared on X: "Our multicenter study found that renal dysfunction, age and Olmesartan…
Jun 28, 2024, 10:40 | Societies
The final results of the KEYNOTE-585 study presented at ESMOGI24
ESMO shared on LinkedIn: "The final results of the KEYNOTE-585 study presented at ESMOGI24 suggest…
Jun 28, 2024, 08:19 | Societies
15 Posts You Should Not Miss From The 1st Day of ESMOGI24
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29…
Jun 28, 2024, 00:56 | Blog
Mark Lewis: This is the football/oncology crossover I’m here for
Mark Lewis shared a post on X: “This is the football/oncology crossover I’m here for,…
Jun 27, 2024, 14:49 | Societies
ESMOGI24 Presentations Summarized By Megan Barnet
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29…
Jun 27, 2024, 14:31 | Societies
Keep up with ESMOGI24 with Teresa Macarulla
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29…
Jun 27, 2024, 12:44 | Societies
Discuss the future of immuno-oncology with Agenus at ESMOGI24
Agenus shared on LinkedIn: "If you are a physician attending ESMOGI24 in Munich from June…
Jun 27, 2024, 10:23 | Insight
ESMO announces the the ESMO GI Ambassadors
The European Society for Medical Oncology (ESMO) shared on LinkedIn: “ESMOGI24: ESMO is excited to…
Jun 27, 2024, 08:37 | Societies
Angela Lamarca: Subgroup analysis on NETTER2
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on X:…
Jun 27, 2024, 08:31 | Societies
Arndt Vogel: Phase I study of the PKMYT1 inhibitor lunresertib in combination with FOLFIRI
Arndt Vogel shared on X: "Phase I study of the PKMYT1 inhibitor lunresertib in combination…
Jun 27, 2024, 08:20 | Societies
Insights from ESMOGI24 by Angela Lamarca
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26…
Jun 26, 2024, 13:47 | Societies
177Lu-DOTATATE as a frontline treatment for somatostatin receptor-positive grade 3 low GEP-NETs
ESMO shared on LinkedIn: "ESMOGI24: Promising data from the phase III NETTER-2 study show that…
Jun 26, 2024, 13:38 | Societies
Angela Lamarca: Opening Press Conference at ESMOGI24
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post by…
Jun 26, 2024, 13:33 | Societies
Nieves Martinez Lago: Real-world efficacy and safety of immune checkpoint inhibitors
Nieves Martinez Lago, Medical Oncologist at University Hospital Complex of Ferrol, shared on X: "Visit…
Jun 26, 2024, 13:27 | Societies
Erman Akkus: Germline mutations are common in non-familial pancreatic cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: "Germline mutations…
Jun 26, 2024, 12:40 | Societies
EGFR co-inhibition in KRAS
Megan Barnet, Medical Oncologist at The Kinghorn Cancer Centre, shared on X: "Great summary from…
Jun 26, 2024, 12:19 | Societies
Brilliant keynote lecture on KRAS inhibitors by Dr. Ryan Corcoran at ESMOGI24
Vittorio Studiale, Medical Oncology resident at AOUP, shared on X: "European Championship of gastrointestinal oncology?…
Jun 18, 2024, 23:25 | Insight
The future of immuno-oncology discussion with Agenus at ESMO GI 2024
Agenus shared a post on LinkedIn: “Are you a physician attending ESMO GI 24? Join…
Jun 10, 2024, 06:13 | Blog
Deniz Can Guven: Come and join us at ESMOGI24
Deniz Can Guven, Medical Oncologist at Health Sciences University, Elazığ City Hospital, shared on X: "Less…
Jun 10, 2024, 01:18 | Societies
Last call to register for the ESMOGI24
ESMO - European Society for Medical Oncology shared a post on LinkedIn: "Last call to…
May 15, 2024, 12:21 | Blog
Pashtoon Kasi: We got a podium presentation with an invited discussant at ESMOGI24
Pashtoon Kasi shared on X/Twitter: "We got a podium presentation with an invited discussant at ESMOGI24.…
Apr 13, 2024, 07:04 | Opinion
5 years of research advances in upper GI cancer - ESMO
ESMO shared a post on LinkedIn: "ESMOGI24: From perioperative care to targeted therapy, 5 years of…
All: 65 Posts: 1 - 100
Special Coverage